Positive Results from Blinatumomab in ALL Patients Tops SPT Week in Review

Top news of the day from across the health care landscape.

5. WHO: Gov.(s) Must Invest 1% of GDP to Curb Increasing Out-of-Pocket Cost

The organization sheds light on the necessary steps to scale up primary health care in low- and middle-income countries. Read More.

4. Minority Patients More Likely to Be Diagnosed with Cancer from ED Visit

The study found that 11% of cancer diagnoses were ED-mediated; and those who went to the ED were more likely to be unmarried, Hispanic, black, or in the lowest income quartile. Read More.

3. Dupilumab Associated in Improvements in CRC

Results from 2 large clinical trials demonstrate that dupilumab is associated with clinical improvements in symptoms of chronic rhinosinusitis (CRC) with nasal polyps. Read More.

2. Disparities in Insulin Use Between Older Adults in Poor and Good Health in T2D

The study include approximately 22,000 patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. Read More.

1. Blinatumomab Shows Positive Results in ALL

Two phase 3 studies evaluating blinatumomab in B-cell acute lymphoblastic leukemia showed positive results for treatment benefit. Read More.